Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Rosenblum

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|August 12, 2005
The immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1Mi-Ae Lyu, Michael G Rosenblum
Physical Review Letters|April 20, 2004
Controlling synchronization in an ensemble of globally coupled oscillatorsMichael G Rosenblum, Arkady S Pikovsky
Biomedicines|July 18, 2017
Targeting of Tumor Neovasculature with GrB/VEGF<sub>121</sub>, a Novel Cytotoxic Fusion ProteinKhalid A Mohamedali, Michael G Rosenblum
Biochemical Pharmacology|December 18, 2007
The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell linesMi-Ae Lyu, Razelle Kurzrock, Michael G Rosenblum
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 9, 2003
Directionality of coupling of physiological subsystems: age-related changes of cardiorespiratory interaction during different sleep stages in babiesRalf Mrowka, Laura Cimponeriu, Andreas Patzak, et al.
Molecular Diagnosis & Therapy|February 22, 2008
Detecting and treating cancer with nanotechnologyKeith B Hartman, Lon J Wilson, Michael G Rosenblum
Chaos (Woodbury, N.Y.)|April 5, 2003
Characterizing direction of coupling from experimental observationsBoris Bezruchko, Vladimir Ponomarenko, Michael G Rosenblum, et al.
Applied Microbiology and Biotechnology|August 19, 2007
Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coliSehoon Kim, Lawrence H Cheung, Weihe Zhang, et al.
Molecular Cancer Therapeutics|October 28, 2003
Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cellsYuying Liu, Lawrence H Cheung, Philip Thorpe, et al.
Molecular Cancer Therapeutics|January 7, 2004
Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agentsYuying Liu, Lawrence H Cheung, Walter N Hittelman, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|August 12, 2005
The immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1Mi-Ae Lyu, Michael G Rosenblum
Physical Review Letters|April 20, 2004
Controlling synchronization in an ensemble of globally coupled oscillatorsMichael G Rosenblum, Arkady S Pikovsky
Biomedicines|July 18, 2017
Targeting of Tumor Neovasculature with GrB/VEGF<sub>121</sub>, a Novel Cytotoxic Fusion ProteinKhalid A Mohamedali, Michael G Rosenblum
Biochemical Pharmacology|December 18, 2007
The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell linesMi-Ae Lyu, Razelle Kurzrock, Michael G Rosenblum
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 9, 2003
Directionality of coupling of physiological subsystems: age-related changes of cardiorespiratory interaction during different sleep stages in babiesRalf Mrowka, Laura Cimponeriu, Andreas Patzak, et al.
Molecular Diagnosis & Therapy|February 22, 2008
Detecting and treating cancer with nanotechnologyKeith B Hartman, Lon J Wilson, Michael G Rosenblum
Chaos (Woodbury, N.Y.)|April 5, 2003
Characterizing direction of coupling from experimental observationsBoris Bezruchko, Vladimir Ponomarenko, Michael G Rosenblum, et al.
Applied Microbiology and Biotechnology|August 19, 2007
Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coliSehoon Kim, Lawrence H Cheung, Weihe Zhang, et al.
Molecular Cancer Therapeutics|October 28, 2003
Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cellsYuying Liu, Lawrence H Cheung, Philip Thorpe, et al.
Molecular Cancer Therapeutics|January 7, 2004
Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agentsYuying Liu, Lawrence H Cheung, Walter N Hittelman, et al.
Pageof 8